Mohamad Alkhouli
Mayo Clinic
430 Papers
539 Citations
Mohamad Alkhouli is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 27, co-authored 296 publications. Previous affiliations of Mohamad Alkhouli include University of Texas Southwestern Medical Center & West Virginia University.
Chat about Author
Papers
Effect of catheter ablation on the hemodynamics of the left atrium
TL;DR: Catheter ablation for AF induced different geometrical changes on the LA and the PVs, therefore influencing flow mixing and vortex patterns in the LA, in addition to overall velocity and WSS distribution.
De-escalation of Antiplatelets After Percutaneous Coronary Intervention: A Bayesian Network Meta-Analysis of Various De-escalation Strategies.
Safi U. Khan,Muhammad Zia Khan,Muhammad Shahzeb Khan,Ahmed Mahmood,Ankur Kalra,Edo Kaluski,Erin D. Michos,Mohamad Alkhouli +7 more
TL;DR: Early de-escalation of DAPT (1-3 months) to monotherapy with a P2Y12 inhibitor instead of aspirin might be a safer and equally effective approach compared with 12 months of D APT in patients with PCI and DES.
Balloon Aortic Valvuloplasty as a Bridge to Aortic Valve Replacement: A Contemporary Nationwide Perspective
TL;DR: In-hospital outcomes of TAVR in these patients were comparable with propensity-score matched patients who underwent TAVr without prior BAV, and major complications, length of stay, and discharge disposition were also comparable.
Efficacy and safety of low dose rivaroxaban in patients with coronary heart disease: a systematic review and meta-analysis
Safi U. Khan,Muhammad Zia Khan,Zain Ul Abideen Asad,Shahul Valavoor,Muhammad Usman Khan,Muhammad Shahzeb Khan,Troy Krupica,Mohamad Alkhouli,Edo Kaluski +8 more
TL;DR: The use of low dose rivaroxaban in patients with coronary heart disease predominantly receiving antiplatelet monotherapy did not reduce cardiovascular or all-cause mortality, and the benefits of preventing MI and stroke were balanced by increased risk of major bleeding.
Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Mediastinal Radiation.
Ayman Elbadawi,Aiham Albaeni,Islam Y. Elgendy,Gbolahan O. Ogunbayo,Ernesto Jimenez,Lorraine D. Cornwell,Arka Chatterjee,Wissam Khalife,Mohamad Alkhouli,Samir R. Kapadia,Hani Jneid +10 more
TL;DR: TAVR provides an important treatment option for this difficult patient population with desirable procedural safety when using SAVR as a benchmark, and is increasingly performed among patients with prior mediastinal radiation.